Preliminary Characterization of a Leptin Receptor Knockout Rat Created by CRISPR/Cas9 System

被引:39
作者
Bao, Dan [1 ,2 ]
Ma, Yuanwu [1 ,2 ]
Zhang, Xu [1 ,2 ]
Guan, Feifei [1 ,2 ]
Chen, Wei [1 ,2 ]
Gao, Kai [1 ,2 ]
Qin, Chuan [3 ,4 ]
Zhang, Lianfeng [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing, Peoples R China
[2] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Key Lab Human Dis Anim Model, State Adm Tradit Chinese Med, Inst Lab Anim Sci, Beijing, Peoples R China
[4] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China
关键词
DIABETIC COMPLICATIONS; FATTY RAT; OBESE; ZUCKER; MUTATION; EXPRESSION; IDENTIFICATION; HYPERGLYCEMIA; PREVENTION; PHENOTYPE;
D O I
10.1038/srep15942
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Leptin receptor, which is encoded by the diabetes (db) gene and is highly expressed in the choroid plexus, regulatesenergy homeostasis, the balance between food intake and energy expenditure, fertility and bone mass. Here, using CRISPR/Cas9 technology, we created the leptin receptor knockout rat. Homozygous leptin receptor null rats are characterized by obesity, hyperphagia, hyperglycemia, glucose intolerance, hyperinsulinemia and dyslipidemia. Due to long-term poor glycemic control, the leptin receptor knockout rats also develop some diabetic complications such as pancreatic, hepatic and renal lesions. In addition, the leptin receptor knockout rats show a significant decrease in bone volume and bone mineral density of the femur compared with their wildtype littermates. Our model has rescued some deficiency of the existing rodent models, such as the transient hyperglycemia of db/db mice in the C57BL/6J genetic background and the delayed onset of glucose intolerance in the Zucker rats, and it is proven to be a useful animal model for biomedical and pharmacological research on obesity and diabetes.
引用
收藏
页数:10
相关论文
共 38 条
[2]   HYPOTHALAMIC AND GENETIC OBESITY IN EXPERIMENTAL-ANIMALS - AUTONOMIC AND ENDOCRINE HYPOTHESIS [J].
BRAY, GA ;
YORK, DA .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :719-809
[3]  
BRAY GA, 1977, FED PROC, V36, P148
[4]   Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials [J].
Calcutt, Nigel A. ;
Cooper, Mark E. ;
Kern, Tim S. ;
Schmidt, Ann Marie .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) :417-429
[5]   Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin [J].
Chehab, FE ;
Lim, ME ;
Lu, RH .
NATURE GENETICS, 1996, 12 (03) :318-320
[6]   Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice [J].
Chen, H ;
Charlat, O ;
Tartaglia, LA ;
Woolf, EA ;
Weng, X ;
Ellis, SJ ;
Lakey, ND ;
Culpepper, J ;
Moore, KJ ;
Breitbart, RE ;
Duyk, GM ;
Tepper, RI ;
Morgenstern, JP .
CELL, 1996, 84 (03) :491-495
[7]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[8]   Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor [J].
Chua, SC ;
Chung, WK ;
WuPeng, XS ;
Zhang, YY ;
Liu, SM ;
Tartaglia, L ;
Leibel, RL .
SCIENCE, 1996, 271 (5251) :994-996
[9]   Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr) [J].
Chua, SC ;
White, DW ;
WuPeng, XS ;
Liu, SM ;
Okada, N ;
Kershaw, EE ;
Chung, WK ;
PowerKehoe, L ;
Chua, M ;
Tartaglia, LA ;
Leibel, RL .
DIABETES, 1996, 45 (08) :1141-1143
[10]   PREVENTION OF DIABETIC NEPHROPATHY IN DB/DB MICE WITH GLYCATED ALBUMIN ANTAGONISTS - A NOVEL TREATMENT STRATEGY [J].
COHEN, MP ;
SHARMA, K ;
JIN, YL ;
HUD, E ;
WU, VY ;
TOMASZEWSKI, J ;
ZIYADEH, FN .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2338-2345